Jankovic J, et al., eds. Parkinson disease and other movement disorders. In: Bradley and Daroff's Neurology in Clinical Practice. 8th ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed April 18, 2025.
Nguyen TT, et al. Nonepileptic paroxysmal disorders in adolescents and adults.2024; https://www.uptodate.com/contents/search. Accessed April 17, 2025.
Lee JA, et al. Personality traits and their effects in patients with hemifacial spasm. Science Report. 2025; doi:10.1038/s41598-025-97368-7.
Caviness, JN. Treatment of myoclonus. 2025; https://www.uptodate.com/contents/search. Accessed April 18, 2025.
Hast M, et al. Patient characteristics and real-world use of botulinum toxins for treatment of hemifacial spasm. Parkinsonism and Related Disorders. 2024; doi: 10.3390/toxins16080362.
Xiang G, et al. The progress in epidemiological, diagnosis and treatment of primary hemifacial spasm. Heliyon. 2024; doi:10.1016/j.heliyon.2024.e38600.
Ami T. Allscripts EPSi. Mayo Clinic. June 16, 2025.
Gulevich, S, et al. Hemifacial Spasm. Medscape. emedicine.medscape.com/article/1170722-print. Accessed June 16, 2025.